Cargando…
Safety and efficacy of intramuscular human placenta‐derived mesenchymal stromal‐like cells (cenplacel [PDA‐002]) in patients who have a diabetic foot ulcer with peripheral arterial disease
The objective of this study was to examine the safety of cenplacel (PDA‐002) in patients with peripheral arterial disease (PAD) and a diabetic foot ulcer (DFU). Cenplacel is a mesenchymal‐like cell population derived from full‐term human placenta. This phase 1, dose‐escalation study investigated cen...
Autores principales: | Wu, Stephanie C, Pollak, Richard, Frykberg, Robert G, Zhou, Wei, Karnoub, Maha, Jankovic, Vladimir, Fischkoff, Steven A, Chitkara, Denesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949952/ https://www.ncbi.nlm.nih.gov/pubmed/28133924 http://dx.doi.org/10.1111/iwj.12715 |
Ejemplares similares
-
Topical Wound Oxygen Therapy in the Treatment of Chronic Diabetic Foot Ulcers
por: Frykberg, Robert G.
Publicado: (2021) -
Comment on Löndahl. Number Eight in the Service of Diabetic Foot Ulcer Healing. Diabetes Care 2020;43:515–517
por: Frykberg, Robert G.
Publicado: (2020) -
Mortality Risk of Charcot Arthropathy Compared With That of Diabetic Foot Ulcer and Diabetes Alone
por: Sohn, Min-Woong, et al.
Publicado: (2009) -
Intramuscular and intratendinous placenta‐derived mesenchymal stromal‐like cell treatment of a chronic quadriceps tendon rupture
por: Maleitzke, Tazio, et al.
Publicado: (2022) -
Mouse models of patent ductus arteriosus (PDA) and their relevance for human PDA
por: Yarboro, Michael T., et al.
Publicado: (2021)